Investing in Drug Companies? Here are 6 Vital Non-Patent Factors to Consider

When drug patents expire, billions of dollars in revenues can disappear overnight as competitors enter the market. Accordingly, many investors focus on drug patents when evaluating drug companies. But, there…

The post Investing in Drug Companies? Here are 6 Vital Non-Patent Factors to Consider appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.